Paltac Corporation
【PALTAC】2026 Financial Results｜Undetermined Sales (YoY Unsure)
PALTAC Corporation announced its fiscal year 2026 financial results for March. The parent company is Medipal Holdings, which holds a controlling stake. While specific figures for sales and profits are unknown, the document indicates support for a tender offer and suggests the complete subsidiary acquisition of the company.
Key Figures
- Voting rights ownership ratio (Parent company: 52.44%)
- Parent company's capital: ¥22,398 million
- Support for and recommendation to apply for the tender offer
AI要約
Overview of Performance
This material relates to PALTAC Corporation's fiscal year 2026 financial results, without detailed figures for sales or profits. Its parent company is Medipal Holdings, holding more than half of the voting rights, and it conducts business mainly in medical, health, and beauty distribution. The governance structure ensures independence while being under the control of the parent company, with final management decisions made by the Board of Directors.
Impact on Shareholders and Future Outlook
The company has expressed support for the tender offer by Medipal Holdings and recommends shareholders to apply. Post-approval, the company is expected to become a wholly owned subsidiary, with the potential delisting from the stock exchange. Although detailed figures for future performance and share handling remain unknown, the change in parent-subsidiary relations is a key focus.
PALTAC Corporation
Company overview · Stock price · Financial data · All IR
